Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-14

FDA Approved: ICATIBANT — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approves the original ANDA for icatibant (generic) by Eugia US LLC for the treatment of acute hereditary angioedema attacks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ICATIBANT (icatibant)

Snippet

ORIG AP for ICATIBANT (ICATIBANT)